Patrick O'Neil to Body Mass Index
This is a "connection" page, showing publications Patrick O'Neil has written about Body Mass Index.
Connection Strength
1.008
-
Pilot evaluation of a personalized commercial program on weight loss, health outcomes, and quality of life. Transl Behav Med. 2021 12 14; 11(12):2091-2098.
Score: 0.153
-
Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial. Lancet. 2018 08 25; 392(10148):637-649.
Score: 0.122
-
The body mass index-mortality relationship in white and African American women. Obes Res. 1998 Jul; 6(4):268-77.
Score: 0.121
-
Impact on psychosocial outcomes of a nationally available weight management program tailored for individuals with type 2 diabetes: Results of a randomized controlled trial. J Diabetes Complications. 2017 May; 31(5):891-897.
Score: 0.110
-
Randomized controlled trial of a nationally available weight control program tailored for adults with type 2 diabetes. Obesity (Silver Spring). 2016 11; 24(11):2269-2277.
Score: 0.108
-
Relations of hedonic hunger and behavioral change to weight loss among adults in a behavioral weight loss program utilizing meal-replacement products. Behav Modif. 2013 Nov; 37(6):790-805.
Score: 0.086
-
Changes in weight control behaviors and hedonic hunger during a 12-week commercial weight loss program. Eat Behav. 2012 Dec; 13(4):354-60.
Score: 0.080
-
Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study. Obesity (Silver Spring). 2012 Jul; 20(7):1426-36.
Score: 0.078
-
Blood naltrexone and 6-beta-naltrexol levels following naltrexone implant: comparing two naltrexone implants. Addict Biol. 2004 Mar; 9(1):59-65.
Score: 0.045
-
Effects of body fat distribution on body size estimation accuracy among obese women. Int J Obes Relat Metab Disord. 1997 Mar; 21(3):250-3.
Score: 0.028
-
Early Weight Loss with Liraglutide 3.0 mg Predicts 1-Year Weight Loss and is Associated with Improvements in Clinical Markers. Obesity (Silver Spring). 2016 11; 24(11):2278-2288.
Score: 0.027
-
The association between food cravings and consumption of specific foods in a laboratory taste test. Appetite. 2008 Sep; 51(2):324-6.
Score: 0.015
-
Effect of NPY5R antagonist MK-0557 on weight regain after very-low-calorie diet-induced weight loss. Obesity (Silver Spring). 2007 Apr; 15(4):895-905.
Score: 0.014
-
Smoking status and weight loss in three weight loss programs. Eat Behav. 2006 Jan; 7(1):61-8.
Score: 0.012
-
Gender, race, and obesity-related quality of life at extreme levels of obesity. Obes Res. 2004 Jun; 12(6):949-55.
Score: 0.011